CD300f immune receptor contributes to healthy aging by regulating inflammaging, metabolism, and cognitive decline.

F Evans, D Alí-Ruiz, N Rego, ML Negro-Demontel, N Lago, FA Cawen, B Pannunzio, P Sanchez-Molina, L Reyes, A Paolino, J Rodríguez-Duarte, V Pérez-Torrado, A Chicote-González, C Quijano, I Marmisolle, AP Mulet, G Schlapp, MN Meikle, M Bresque, M CrispoE Savio, C Malagelada, C Escande, Hugo Peluffo

Research output: Contribution to journalArticleResearchpeer-review

1 Citation (Scopus)
1 Downloads (Pure)

Abstract

Emerging evidence suggests that immune receptors may participate in many aging-related processes such as energy metabolism, inflammation, and cognitive decline. CD300f, a TREM2-like lipid-sensing immune receptor, is an exceptional receptor as it integrates activating and inhibitory cell-signaling pathways that modulate inflammation, efferocytosis, and microglial metabolic fitness. We hypothesize that CD300f can regulate systemic aging-related processes and ultimately healthy lifespan. We closely followed several cohorts of two strains of CD300f-/- and WT mice of both sexes for 30 months and observed an important reduction in lifespan and healthspan in knockout mice. This was associated with systemic inflammaging, increased cognitive decline, reduced brain glucose uptake observed by 18FDG PET scans, enrichment in microglial aging/neurodegeneration phenotypes, proteostasis alterations, senescence, increased frailty, and sex-dependent systemic metabolic changes. Moreover, the absence of CD300f altered macrophage immunometabolic phenotype. Taken together, we provide strong evidence suggesting that myeloid cell CD300f immune receptor contributes to healthy aging.
Original languageEnglish
Article number113269
JournalCell reports
Volume42
Issue number10
DOIs
Publication statusPublished - 31 Oct 2023

Fingerprint

Dive into the research topics of 'CD300f immune receptor contributes to healthy aging by regulating inflammaging, metabolism, and cognitive decline.'. Together they form a unique fingerprint.

Cite this